A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences

A comparison of biologicals in the treatment of adults with severe asthma – real-life experiences

Abstract Background Anti-IgE (omalizumab) and anti-IL5/IL5R (reslizumab, mepolizumab and benralizumab) treatments are available for severe allergic and eosinophilic asthma. In these patients, studies have shown beneficial effects in oral corticosteroid use and exacerbations. The aim of this retrospe...

Full description

Bibliographic Details
Main Authors: Emma Kotisalmi, Auli Hakulinen, Mika Mäkelä, Sanna Toppila-Salmi, Paula Kauppi
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Asthma Research and Practice
Subjects:
Anti-IgE
Anti-IL5
Asthma
Biological therapy
Corticosteroid
Eosinophils
Online Access:http://link.springer.com/article/10.1186/s40733-020-00055-9

Internet

http://link.springer.com/article/10.1186/s40733-020-00055-9

Similar Items